DIALYSIS PRECURSOR COMPOSITION
    1.
    发明申请
    DIALYSIS PRECURSOR COMPOSITION 审中-公开
    DIALYSIS前身组成

    公开(公告)号:US20130183389A1

    公开(公告)日:2013-07-18

    申请号:US13805040

    申请日:2011-06-20

    IPC分类号: A61K33/14

    摘要: The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consist of powder components comprising sodium chloride, at least one dry acid and at least one magnesium salt, and optionally potassium salt, calcium salt, and glucose. According to the invention said at least one magnesium salt and said optional glucose, are present as anhydrous components in said dialysis acid precursor composition.

    摘要翻译: 本发明涉及一种透析酸前体组合物,用于制备透析酸浓缩液,并与水和含碳酸氢盐的浓缩液混合成即用型透析溶液。 所述透析酸前体组合物由包含氯化钠,至少一种干酸和至少一种镁盐,以及任选的钾盐,钙盐和葡萄糖的粉末组分组成。 根据本发明,所述至少一种镁盐和所述任选的葡萄糖以所述透析酸前体组合物中的无水组分存在。

    Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
    5.
    发明申请
    Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis 审中-公开
    制备用于腹膜透析的药物的药液的制备方法

    公开(公告)号:US20060046975A1

    公开(公告)日:2006-03-02

    申请号:US10538791

    申请日:2003-12-10

    IPC分类号: C13F3/00 A61K31/70

    摘要: A method for preparing a medical solution, comprising the steps of a) providing a solution comprising one or more acetylated or deacetylated amino sugar/sugars in at least one compartment of a container in a concentration from 15% by weight to 40% by weight, with the basis of the solution in said at least one compartments, and b) terminal sterilisation of said at least one compartment and the contents therein, is disclosed, as well as a solution used for preparing the medical solution, a container containing said solution, and use of said solution for the manufacture of a medicament for peritoneal dialysis.

    摘要翻译: 一种制备医用溶液的方法,包括以下步骤:a)在容器的至少一个室中提供浓度为15重量%至40重量%的一种或多种乙酰化或脱乙酰氨基糖/糖的溶液, 其中所述至少一个隔室中的溶液的基础,以及b)所述至少一个隔室及其中的内容物的末端灭菌,以及用于制备医用溶液的溶液,容纳所述溶液的容器, 以及使用所述溶液制造用于腹膜透析的药物。